CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia - GlobalData

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia - GlobalData
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia
Published Sep 01, 2016
253 pages — Published Sep 01, 2016
Price US$ 1,995.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

The population of Australia in 2015 was 23.86 million, having grown at a CAGR of 2% from 2008. Medicare is Australias public health insurance scheme, and provides free or subsidized healthcare services to the Australian population. The government is attempting to reduce the barriers to manufacturing drugs and encourage exports through the introduction of various new policies.

In 2015, the government spent $22.03 billion on R&D on medical and health science and exported $3.53 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $22.30 billion in 2015 and is projected to reach $25.20 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 2%. The medical device market was valued at $8.85 billion in 2015 and is projected to grow at a CAGR of 0.1% to $11.44 billion by 2020. These positive growth trends can be primarily attributed to -
- An increasingly elderly population
- Universal health coverage
- Government initiatives

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Australia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Alphapharm, Apotex, Aspen Pharmacare (Aspen), Pfizer and AstraZeneca; and profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Siemens Healthcare, Philips Healthcare, GSK and Alcon
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the countrys healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the countrys political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Australian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Australias healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Australias healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

  
Source:
Document ID
GDHC0068CHR
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents512
  List of Tables85
  List of Figures134
Introduction171
  GlobalData Report Guidance171
Overview of Pharmaceutical and Medical Device Markets18103
  Pharmaceutical Market181
    Market Overview183
    Pharmaceutical Exports and Imports211
    Supply Channels221
      Wholesalers/Distributors231
      Pharmacists and Hospitals231
      Manufacturers241
    Market Segments241
      Generic Drugs241
      Biologics/Biosimilars251
      Over-the-Counter Drugs261
    Overview of Top Five Disease Areas271
      Central Nervous System281
      Cardiovascular System281
      Anti-neoplastic and Immunomodulating Agents291
      Alimentary Tract and Metabolism291
      Respiratory System291
    Major Players291
      Alphapharm301
        Overview301
        Product Portfolio311
        Research and Development311
        SWOT Analysis321
      Apotex331
        Overview331
        Product Portfolio341
        Research and Development351
        SWOT Analysis354
      Aspen Pharmacare391
        Overview391
        Product Portfolio401
        Research and Development411
        SWOT Analysis414
      Pfizer451
        Overview451
        Product Portfolio461
        Research and Development471
        SWOT Analysis487
      AstraZeneca551
        Overview551
        Product Portfolio561
        Research and Development574
        SWOT Analysis618
  Medical Device Market691
    Market Overview693
    Overview of the Top Five Segments721
      In Vitro Diagnostics732
      Orthopedic Devices752
      Cardiovascular Devices772
      Diagnostic Imaging792
      Ophthalmic Devices812
    Major Players831
      GE Healthcare841
        Overview841
        Product Portfolio842
        Research and Development862
        SWOT Analysis886
      Siemens Healthcare941
        Overview941
        Product Portfolio951
        Research and Development951
        SWOT Analysis966
      Philips Healthcare1021
        Overview1021
        Product Portfolio1021
        Research and Development1031
        SWOT Analysis1035
      GlaxoSmithKline1081
        Overview1081
        Product Portfolio1091
        Research and Development1101
        SWOT Analysis1106
      Alcon1161
        Overview1161
        Product Portfolio1171
        Research and Development1171
  Market Drivers and Barriers1181
    Drivers1181
    Barriers1192
Market Access12142
  Reimbursement and Payer Landscape1211
    Overview of Healthcare System1211
    Reimbursement Process1214
      Reimbursement Process for Pharmaceutical Products1252
      Reimbursement Process for Medical Devices1271
    Overview of Insurance Providers1281
      Public Insurance1282
      Private Insurance1304
    Patient Share in Healthcare Spending1341
    Price Trend in Healthcare Services1351
    Pricing Policies1361
      Cost Plus Method1361
      Reference Pricing1371
      Weighted Average Monthly Treatment Cost1371
  Regulatory Landscape1381
    Overview of Regulatory Agencies1381
    Market Authorization Procedure for Pharmaceutical Products1394
    New Medical Device Approval Process1436
    Licensing Process for Pharmaceutical and Medical Device Manufacturing1491
    Licensing Process for Pharmaceutical Exports and Imports1501
    Intellectual Property Rights1511
      Patents1513
      Trademarks1541
    Clinical Trial Regulations1552
    Pharmaceutical Advertising Regulations1572
    Pharmacy Regulations1591
    Labeling and Packaging Regulations1603
Country Analysis16367
  Political Environment1631
    Political Structure1632
    Current Political Environment1651
    Healthcare Policy Initiatives1652
  Economic Landscape1673
  Economic Indicators1701
    Gross Domestic Product1701
      GDP per Capita1702
      Annual Change in GDP1722
    Gross National Income1741
    Inflation1751
      Consumer Price Index1752
      Annual Change in Consumer Price1772
    Currency Exchange Rate1791
    Foreign Direct Investment1801
    Foreign Exchange Reserves1811
    Trade Balance1821
      Imports of Goods and Services1821
      Exports of Goods and Services1831
    Government Structural Balance1841
    Government Net Debt1852
    Major Industries1871
  Demographics1881
    Population1883
      Urban and Rural Population Shares1911
      Distribution by Age Groups1923
      Birth Rate1951
      Mortality1961
      Major Causes of Mortality1971
      Health Status by Gender and Age1984
      Gender Ratio2021
      Life Expectancy2031
    Education and Literacy2044
    Employment2081
    Disease Burden2091
  Healthcare Infrastructure2101
    Healthcare Facilities2101
      Public and Private Hospitals2103
      Diagnostic Facilities2132
    Healthcare Parameters2151
      Hospital-Bed-to-Population Ratio2152
      Doctor-to-Population Ratio2171
    Environmental Health2181
      PM2.5 Emissions2181
      Carbon Dioxide Emissions2192
    Healthcare Personnel2211
      Nurses-to-Population Ratio2211
      Pharmacists-to-Population Ratio2221
      Dentists-to-Population Ratio2231
  Healthcare Expenditure2241
    Overview2241
    Major Components of Healthcare Spending2251
    Public and Private Sector Share2261
    Spending in Pharmaceutical Research and Development2271
  Trade Associations2281
    Australian Pharmaceutical Marketing and Research Group2281
    Pharmacy Guild of Australia2281
    Generic Medicines Industry Association2281
  Trade Fairs2291
Opportunities and Challenges2303
  Opportunities2301
  Challenges2312
Appendix23321
  Abbreviations2334
  Bibliography23713
  Research Methodology2502
    Coverage2501
    Secondary Research2511
    Forecasts2511
    Expert Panel2511
  Disclaimer2522

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia" Sep 01, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData/CountryFocus-Healthcare-Regulatory-and-Reimbursement-Landscape-Australia-2085-18093>
  
APA:
GlobalData. (2016). CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia Sep 01, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData/CountryFocus-Healthcare-Regulatory-and-Reimbursement-Landscape-Australia-2085-18093>
  
US$ 1,995.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.